|
|
||||||||
Unité de Biologie Moléculaire du Gène, Institut Pasteur, Paris, France
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
We analyzed the kinetics of B cell differentiation in both locations, from embryos at day 15 of gestation to birth, by flow cytometry and PCR analysis of the Ig heavy chain rearrangements followed by cloning and sequencing the complementarity determining region 3 (CDR3)4 region. We show that the first B lymphocytes (surface Ig+ (sIg+)) are detectable in fetal liver and bone marrow at day 17 of development. B cells represent a higher proportion of the B220+ compartment in bone marrow than in fetal liver. The analysis of heavy chain gene rearrangements from fetal liver cells shows a sudden shift from 80% of nonproductive rearrangements at day 17 of gestation to 30% at day 19 (birth time). Rearrangements isolated from bone marrow exhibit a higher proportion of N sequence additions when compared with those isolated from fetal liver. The accelerated maturation of B cells in bone marrow together with the intrinsic differences in the rearrangements observed in both sites allow us to propose that liver and marrow environment provide different selective constraints on B cell differentiation.
| Materials and Methods |
|---|
|
|
|---|
C57BL/6 mice were purchased from Iffa-Credo (LArbresle, France). Experiments were performed with animals bred in specific pathogen-free barrier-free conditions in the Pasteur Institutes animal facilities. Timed pregnancies were obtained by mating mice over 1 night. The following day was considered to be day 0 of pregnancy. Newborn refers to the day of birth (day 19). For cell suspension preparations, the uterus from pregnant females was isolated and extensively washed in medium. Embryos were then isolated and the absence of contaminating blood from the mother ascertained by the absence of sIg+ cells, as detected by FACS staining at day 15, both in bone marrow and fetal liver. Direct LPS stimulation of fetal liver and bone marrow preparations at days 14 and 15 also shows the absence of detectable mature B lymphocytes. Cell suspensions were obtained as previously described (8).
Fluorescence surface staining and flow cytometry
Single cell suspensions were prepared from various organs and viable cells were determined using trypan blue exclusion. About 106 living cells per sample were stained as described (9) with phycoerythrin anti-B220 (PharMingen, San Diego, CA) and FITC anti-µ (Jackson ImmunoResearch, West Grove, PA). Dead cells were eliminated by propidium iodide exclusion and at least 5,000 events recorded per sample. Fluorescence was measured with FACScan flow cytometer (Becton Dickinson, Sunnyvale, CA) using Cell Quest software.
CDR3 length analysis with immunoscope
The repertoire analysis of Ig heavy chain has been
described in detail elsewhere (10). In brief, PCR amplifications were
performed with a sense primer specific for the J558 family and an
antisense primer specific for the intron region 3' of
JH4 for DNA amplification (11). A run-off elongation
with a fluorescent primer specific for JH4 was then
performed on the amplification product, and the fluorescent PCR
fragments covering the CDR3 region were separated on a sequencing gel
run in an automated DNA sequencer (Applied Biosystems, Foster City,
CA). Using software, the bands detected on the gel were converted into
peaks whose length as well as intensity (in arbitrary units) are known.
Each peak corresponds to one band and represents the multiple
rearrangements with a particular CDR3 length. The pattern seen with any
diverse population of cells (see adult bone marrow in Fig. 1
) is that of a normal size distribution
represented by the gaussian-shaped curve. Equivalent amounts of DNA
were used in all experiments.
|
J558-JH4 amplification products were purified by electroelution, cloned into pCRII using the TA cloning kit (Invitrogen, San Diego, CA), and recombinant clones were sequenced using the T7 sequencing kit (Pharmacia, Uppsala, Sweden).
To avoid bias due to cloning, repeated sequences were not considered.
| Results |
|---|
|
|
|---|
The first major population of B cell progenitors that can be
identified by phenotype corresponds to the pro- and pre-B lymphocytes,
characterized by the expression of B220, the B cell-specific splice
variant of the surface marker CD45. After successful rearrangement of
both Ig chains, a complete IgM molecule can be produced and expressed
on the cell surface. The B220+µ+
population thus encompasses the immature and mature B lymphocytes. To
study the progression of the different maturation stages during the
last part of fetal development, liver and bone marrow cells from day 15
to 18 embryos as well as from neonates (day 19) were analyzed by flow
cytometry for the expression of B220 and surface µ heavy chain. By
flushing the four limbs, we collected about 2 x 106
cells in day 17 or 18 embryos, and 10 x 106 cells in
neonates. For each stage of development, at least four embryos were
studied individually. Variations in the percentages of
B220+µ- and
B220+µ+ populations between individuals lead
to a maximum SD of 20% in the ratio of these two populations. While
day 15 fetal livers contained about 0.2% of
B220+µ- cells in all the studied embryos,
the first sIg-bearing B lymphocytes were detectable in the liver at day
17, representing 0.4% of the B220+ population in the liver
(Fig. 1
). This result correlates with previous observations on fetal
liver cells from BALB/c mice (12). Surprisingly, the B lymphocytes
already represented 3% of the B220+ population in the
marrow of day 17 embryos, suggesting that maturation of B lymphocytes
in marrow precedes maturation in liver. Thereafter, the B cell
compartment (B220+µ+) developed rapidly,
representing 2.6% of the B220+ population in liver cells
from day 18 embryos and 6.8% in the marrow, and around 10% of the
B220+ population in these two organs at day 19 (Fig. 1
). In
an adult bone marrow, the µ+ population represents 27%
of the B220+ cells, but it has been estimated that half of
this B220+µ+ population corresponds to
recirculating mature B lymphocytes (13). The ratio between pre-B and B
cells is thus already close to the adult ratio in the newborn lymphoid
organs.
Ontogenic analysis of the Ig heavy chain rearrangements
Profiles of CDR3 length diversity. The first DJH rearrangements in the fetal liver are detected around day 12, while the number of VHDJH rearrangements increases mainly from day 15 on (11). We used the immunoscope technique to study the developing repertoire of Ig heavy chain rearrangements in fetal liver from day 15 embryos to newborns (10). In the mouse, the several hundred VH gene segments have been grouped in 13 families based on DNA sequence homologies (14, 15, 16, 17, 18). The J558 family encompasses about 100 genes and is the most represented in the adult mouse. In C57BL/6 mice, they represent 50% of the adult repertoire and are also the most representative family in fetal liver B cell precursors (19, 20, 21).
We have compared the profiles obtained after amplification of
genomic DNA from fetal liver day 15 embryos to newborn mice.
Amplification was performed using a primer specific for the J558 family
with a primer specific for the sequences 3' of JH4 (11),
and run-off was done using a fluorescent primer specific for
JH4. We performed the same experiments with the VHQ52
primer with similar results (data not shown). The study of genomic DNA
allowed us to estimate the ratio of productive vs nonproductive
rearrangements, allowing the distinction between intrinsic genetic
events and cellular selection. Figure 2
shows a representative amplification of liver cells (day 17 to 19)
compared with amplifications of neonate and adult bone marrow. Each
peak of these profiles corresponds to a single band on a 1-bp
discriminating polyacrylamide gel. Thus, these bands are able to
correspond to one or several rearrangements sharing the same
VH, the same JH, and the same CDR3 length. It
has been shown that the relative intensities of the different peaks
reflect the representation of the corresponding CDR3 length in the
population before amplification (22, 23).
|
It has been shown that the insertion of nongermline-encoded (N) nucleotides at the junction of different gene segments is rare early in ontogeny due to the low activity of the terminal deoxynucleotide transferase (TdT) (26, 27, 28, 29, 30). When the amplification profiles obtained from fetal liver are compared with the profiles obtained from adult bone marrow, we can observe a shift of the profile to larger sizes. This observations indicates that the TdT activity in the adult increases the mean length of the CDR3 by three amino acids.
Sequence analysis of heavy chain rearrangements expressing J558 and
JH4.
To further analyze the heavy chain rearrangements, we cloned and
sequenced J558-JH4 rearrangements from fetal liver at
day 17, 18, and newborn and from newborn bone marrow. A summary of the
numbers of sequences obtained and their characteristics is shown in
Table I
.
|
Figure 3
shows the CDR3 sequences
obtained from newborns, liver, and bone marrow. Short homologies at or
near coding sequence breakpoints have been proposed to mediate
VHDJH joining and lead to the appearance of
certain variable regions at increased frequency in fetal repertoires
(27, 29, 31). This type of junction was found in 16 independent
sequences from all the amplified samples. Interestingly, sequences from
newborn bone marrow contained more N additions than sequences from
newborn liver, both at the level of percentage of sequences with N
additions (13% in liver and 30% in bone marrow), and of number of
added nucleotides (an average of one per liver sequence and four per
bone marrow sequence).
|
|
| Discussion |
|---|
|
|
|---|
The CDR3 of the mature Ig heavy chain region encompasses the D segment together with its junctional sequences to VH and JH and is thus diverse in size and sequence. This region has the highest variability in the Ig molecule (33), contributing to a large extent to the diversity found in the primary Ig repertoire in the mouse. Our study of the J558-JH4 CDR3 regions at different days of development corresponding to the detection of sIgM provides an insight into the development and selection processes of B cells in the neonates.
VHDJH rearrangements are detectable in day 15
fetal liver, and their number increases rapidly thereafter (11). This
is in accordance with the profiles we obtained using immunoscope, where
day 15 fetal liver gave rise to sporadic and weak bands corresponding
to J558-JH4 rearrangements on Immunoscope profiles (data not shown),
while day 17 fetal liver showed a normal distribution encompassing a
large diversity of CDR3 sizes (Fig. 2
). However, day 17 fetal liver
contains 80% of nonproductive rearrangements. Within 2 days, this
percentage drops drastically to 30% at birth, in correlation with the
increasing percentage of B220+µ+ cells. In a
random set of VHDJH rearrangements, around 70%
are expected to be nonproductive (34). However, due to selection of
cells bearing functional heavy chains, VHDJH
rearrangements from sIg-negative pre-B cells from the bone marrow are
generally around 80% productive (24, 25). A similar analysis done in
light chain rearrangements in fetal liver shows a shift of 33 to
46% of productive rearrangements from day 14 to 16 of gestation. The
total number of
-chain productive rearrangements at day 16 is around
2 x 104, which could correspond to the actual number
of B cells found as sIg+ by day 17 (35).
Our results, showing that a diverse repertoire is generated in fetal liver before any detectable selection for cells that undergo productive rearrangements, can be explained in two ways. First, we could envisage that before day 17 of gestation, the putative ligand(s) driving expansion of cells expressing heavy chain with the surrogate light chains is not present (36). This would thus be an absence of positive selection. Second, cells that undergo nonproductive rearrangements would not be eliminated from fetal liver until around birth. This absence of negative selection could account for the striking expansion of B cell precursors between days 12 and 16 of gestation. The third possibility is that most cells are synchronized in their development. Recently, the generation of hematopoietic progenitors in early embryos has been studied carefully. It was shown that hematopoietic precursors originate in the paraaortic splanchnopleura/aorta-gonad-mesonephros regions (37, 38, 39). By day 10 of development, circulating hematopoietic progenitors can be detected in embryonic circulation, reaching a maximum by day 12 (8), and day 11 fetal liver cells have been shown to be capable of long-term reconstitution of irradiated recipients (39). If we assume that the colonization of fetal liver by stem cells is not an ongoing process but occurs predominantly between days 11 and 12, the results presented here suggest that the differentiation and selection processes between pre-B to B cells in the fetal liver are not progressive but occur in one synchronous wave. Similar conclusions were drawn from studies on the transition from dependence to independence of fetal liver B cell precursors on stromal cells (40). If correct, this hypothesis implies that a stem cell requires 7 days to differentiate into mature B cells in the fetal liver environment. While there is no direct evidence for the existence of a positively selecting ligand for pre-B cells in bone marrow and fetal liver, our third hypothesis seems more plausible. The observations that from day 15 to 17, the diversity of rearrangements and, later, the percentage of productive rearrangements and sIg+ B cells increase drastically is an argument in favor of a certain degree of synchronization in B cell precursors in fetal liver.
Day 17 fetal liver rearrangements are highly diverse when the sizes of
CDR3 are probed (Fig. 2
). Yet, day 17 fetal liver composes 80% of
nonproductive rearrangements, compared with 33% in newborn liver. In
addition, we found a compelling difference in the presence of N
additions between liver and bone marrow at the same age (newborn). As N
additions reflect activation of the TdT, the observed differences could
be a consequence of a difference in the expression of TdT between
newborn liver and newborn bone marrow, or of a difference of kinetics
of differentiation of a stem cell into mature B cells in both embryonic
environments. This second possibility correlates with the more rapid
appearance of µ+ cells in the B220+
population in bone marrow when compared with liver. The
B220+µ- and
B220+µ+ compartments do not exhibit the same
kinetics in fetal liver and bone marrow between days 17 and 19. It
appears that while the B220+µ- cells
proliferate extensively in liver, maturation to sIg+ cells
is favored in the bone marrow in the absence of comparable expansion of
the B220+µ- compartment. Thus, our results
suggest that liver and marrow impose different environmental
constraints in the differentiating B cell progenitors.
The observed differences in the maturation of B cells in the liver compared with bone marrow do not significantly affect the peripheral pool of cells in newborn animals. At this stage, more than 90% of the mature B cells are of liver origin. Bone marrow production of B cells becomes predominant after the second week of age.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Present address: Dr. Sylvie Delassus, Leukemia Research Fund Center, Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB U.K. ![]()
3 Address correspondence and reprint requests to Dr. Ana Cumano, Biologie Moléculaire du Gène, Institut Pasteur, 28, rue du Docteur Roux, 75 724 Paris Cedex 15, France. ![]()
4 Abbreviations used in this paper: CDR3, complementarity determining region 3; RF, reading frame; TdT, terminal deoxynucleotide transferase; sIg, surface Ig; N, nongermline-encoded. ![]()
Received for publication August 4, 1997. Accepted for publication December 9, 1997.
| References |
|---|
|
|
|---|
Light chain rearrangement in mouse fetal liver. J. Immunol. 153:1150.[Abstract]
5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice. Cell 77:133.[Medline]
This article has been cited by other articles:
![]() |
B. Gozalbo-Lopez, P. Andrade, G. Terrados, B. de Andres, N. Serrano, I. Cortegano, B. Palacios, A. Bernad, L. Blanco, M. A. R. Marcos, et al. A Role for DNA Polymerase {micro} in the Emerging DJH Rearrangements of the Postgastrulation Mouse Embryo Mol. Cell. Biol., March 1, 2009; 29(5): 1266 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Bolland, A. L. Wood, R. Afshar, K. Featherstone, E. M. Oltz, and A. E. Corcoran Antisense Intergenic Transcription Precedes Igh D-to-J Recombination and Is Controlled by the Intronic Enhancer E{micro} Mol. Cell. Biol., August 1, 2007; 27(15): 5523 - 5533. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. J. Vosshenrich, A. Cumano, W. Muller, J. P. Di Santo, and P. Vieira Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment PNAS, July 27, 2004; 101(30): 11070 - 11075. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sinkora, J. Sun, J. Sinkorova, R. K. Christenson, S. P. Ford, and J. E. Butler Antibody Repertoire Development in Fetal and Neonatal Piglets. VI. B Cell Lymphogenesis Occurs at Multiple Sites with Differences in the Frequency of In-frame Rearrangements J. Immunol., February 15, 2003; 170(4): 1781 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. D. Rossi, K. L. Medina, K. Garrett, G. Kolar, P. C. Comp, L. D. Shultz, J. D. Capra, P. Wilson, A. Schipul, and P. W. Kincade Relatively Normal Human Lymphopoiesis but Rapid Turnover of Newly Formed B Cells in Transplanted Nonobese Diabetic/SCID Mice J. Immunol., September 15, 2001; 167(6): 3033 - 3042. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Giorgetti and J. L. Press Somatic Mutation in the Neonatal Mouse J. Immunol., December 1, 1998; 161(11): 6093 - 6104. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, C. Hayward, R. Shinde, R. Christenson, S. P. Ford, and J. E. Butler Antibody Repertoire Development in Fetal and Neonatal Piglets. I. Four VH Genes Account for 80 Percent of VH Usage During 84 Days of Fetal Life J. Immunol., November 1, 1998; 161(9): 5070 - 5078. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |